|
This combination of diet and exercise is certainly very critical for all bc patients. The established medical care team does not push this as much as they obviously should is an economic incentive issue. Drug makers do not benefit from this regimen while other chemo or even Herceptin use has a great deal of profit incentives although the advantage from the use is far less than the combination reported in this article. Even oncs may have the conflict of interest issue on this subject.
__________________
Ann
Stage 1 dx Sept 05
ER/PR positive HER2 +++ Grade 3
Invasive carcinoma 1 cm, no node involvement
Mastec Sept 05
Annual scans all negative, Oct 06
Postmenopause. Arimidex only since Sept 06, bone or muscle ache after 3 month
Off Arimidex, change to Femara 1/12-07, ache stopped
Sept 07 all tests negative, pass 2 year mark
Feb 08 continue doing well.
Sep 09 four year NED still on Femara.
|